Human Vaccines & Immunotherapeutics
Volume 20, 2024 - Issue 1
HPV
Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment
Hinpetch Daungsupawonga Private Academic Consultant, Phonhong, Lao People’s Democratic RepublicCorrespondence[email protected]
https://orcid.org/0009-0002-5881-2709View further author information
https://orcid.org/0009-0002-5881-2709View further author information & Viroj Wiwanitkitb Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Indiahttps://orcid.org/0000-0003-1039-3728View further author information
https://orcid.org/0000-0003-1039-3728View further author information